U.S. Markets close in 1 hr 11 mins

Clovis Oncology Stock Sinks on Dim View of Cancer Drug Sales

Josh Nathan-Kazis

Shares of the biotech firm sank Wednesday morning after an analyst at Goldman Sachs downgraded the stock from Neutral to Sell.